# A Clinical Trial of Parkinson's Disease Treatment by HiPSCs Derived Dopaminergic Neural Precursor Cells

> **NCT06145711** · NA · RECRUITING · sponsor: **Shanghai East Hospital** · enrollment: 3 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **OTHER:** hiPSC-DAP

## Key facts

- **NCT ID:** NCT06145711
- **Lead sponsor:** Shanghai East Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-23
- **Primary completion:** 2025-12-22
- **Final completion:** 2025-12-22
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06145711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06145711, "A Clinical Trial of Parkinson's Disease Treatment by HiPSCs Derived Dopaminergic Neural Precursor Cells". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06145711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*